The TGFB1 gene helps make a signaling protein that tells cells when to grow, calm inflammation, heal injuries, and maintain tissues such as bone and blood vessels. If this signal is too weak or too strong, the body may heal in an unbalanced way, which can lead to excess scarring or, in rare inherited conditions, painful bone thickening and muscle weakness. Some differences in this gene can change how active this pathway is. Most variants have little effect on health.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes carry the directions for producing proteins, the parts of cells that do much of the work. Other genes mainly guide when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To go into this topic in more detail, you can learn more in the LearnHub.
Overview
TGFB1Gene function
What if the gene works
The TGFB1 gene helps control how cells grow, divide, and make supportive tissue. It also helps guide immune activity and wound healing.
Risk
What if the gene does not work
Variants in the TGFB1 gene can cause painful thickening of the long bones with muscle weakness and walking difficulty, or, less often, severe early gut inflammation. Effects range from mild to more pronounced depending on the variant.
Treatment
What does that mean for your treatment
No TGFB1-specific treatment or drug-choice approach is currently established; care is based on the person’s symptoms and the condition involved rather than on the TGFB1 gene itself. The TGFB1 gene and its signaling pathway are being studied as drug targets and biomarkers in fibrosis, cancer, and immune conditions, but these uses are not standard treatment guidance.
Conditions associated with TGFB1
Gene function
What if the gene works
The TGFB1 gene helps your body coordinate how cells grow, settle into their jobs, and respond to everyday wear and tear. Its protein acts like a messenger, carrying signals between cells so tissues stay balanced. Understanding what the TGFB1 gene does in the body helps make sense of how healing, immune balance, and normal cell behavior are guided.
The TGFB1 gene helps cells respond to signals that tell them when to divide and when to slow down. This supports steady tissue upkeep and more organized growth.
Its protein helps guide cells as they mature into more specialized cell types. This supports normal development and the daily maintenance of many tissues.
After routine strain or a minor injury, the TGFB1 gene helps coordinate repair. It also encourages cells to make supportive material, including collagen, that gives tissues structure.
The TGFB1 gene helps fine tune immune activity so responses stay measured. This can help limit unnecessary inflammation while still supporting normal healing signals.
What is a variant?
Within a gene, a genetic variant is a small difference in its DNA sequence. These differences are common and are part of normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes gene function to a greater degree and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the TGFB1 gene change how the TGFB1 protein is folded, processed, or released, showing how TGFB1 gene variants affect protein function. Some make the protein easier to activate, leading to stronger cell signaling, while others reduce stability or secretion and lower signaling. Milder variants may shift this signal a little, but more disruptive variants can change it more clearly. In people with TGFB1 related conditions, larger functional changes often track with earlier or more pronounced features.
How variants are linked to conditions
Pathogenic variants in the TGFB1 gene cause Camurati-Engelmann disease, a rare inherited condition affecting the long bones. People with this TGFB1 gene change may develop bone pain, muscle weakness, easy fatigue, and a characteristic waddling walk, often beginning in childhood. In this setting, finding a disease-causing variant in the TGFB1 gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, particularly when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce health risk related to the TGFB1 gene. Risk can vary depending on the exact gene change and other parts of your health and family background, so personal guidance from a doctor or genetic counselor can be helpful.
Inheritance of TGFB1 variants
For families tracing the TGFB1 inheritance pattern, disease-causing variants linked to Camurati-Engelmann disease are usually inherited in an autosomal dominant way. That means a person needs one altered copy of the TGFB1 gene to have the condition. If a parent carries the variant, each child has a 50% chance of inheriting it. Some people have a new (de novo) variant in the TGFB1 gene, which means it started in them and was not passed down from either parent.
What does my TGFB1 result mean for my family?
For TGFB1, a disease-causing result is most often linked to Camurati-Engelmann disease, which usually runs in families in a dominant way. This means close relatives, such as a parent, brother, sister, or child, may also carry the same gene change and could have symptoms or develop them later. Some cases happen for the first time in one family, so a parent does not always have the variant.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the TGFB1 gene is usually done on a blood or saliva sample. In TGFB1 genetic testing, a lab reads the DNA code of the gene and compares any variant with trusted reference data. Results may show a benign variant, a variant of uncertain significance, or a pathogenic variant.
When should I consider getting a genetic test?
Genetic testing for the TGFB1 gene may be worth considering if someone has unexplained bone pain, muscle weakness, a waddling walk, or thickening of the long bones, especially when these findings run in the family. A disease-causing change in TGFB1 can confirm a rare inherited bone condition called Camurati-Engelmann disease and help clarify whether relatives may also be affected.
A genetic result is only one part of your health story
Genetic test findings can be very informative, yet how much they explain depends on the condition and on the kind of variant involved. Over time, body function is also shaped by factors such as lifestyle, environment, age, and medical history. For some conditions, especially those affected by many genes, genetic information provides context more than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, these results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down or move a drug through the body differently, so the same treatment may work better for one person and less well for another. These common genetic differences can also influence how sensitive someone is to a medicine and how likely they are to have side effects. Medication response is shaped by genetics along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines the way genetic differences affect the response to medicines. It studies links between genes and medications to help explain why the same treatment can work differently in different people. With many drugs, genes influence either how strongly the medicine works or how the body handles it. This information can support treatment choices that are both more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the TGFB1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about medicines or side effects are best discussed with your doctor. Some studies have looked at TGFB1 and how people respond to certain cancer, transplant, or scarring-related treatments, but this has not become routine care.
History
Researchers began tracing the history of the TGFB1 gene in the late 1970s and early 1980s, when scientists studying cancer cells noticed substances that could strongly change how nearby cells behaved. The protein linked to this gene was identified as part of the transforming growth factor family, a name that came from those early laboratory observations. Building on this early work, scientists purified the protein, mapped the gene, and cloned it during the 1980s, which helped establish it as a major signaling molecule in human biology. Its discovery also helped shift research toward understanding how cells communicate during growth, repair, and scarring. Over time, descriptions became more precise as researchers separated TGFB1 from related family members and linked it to several inherited and acquired health conditions.